Research and Markets: Chinese CRO Company Report - ShangPharma
by Business Wire
Research and Markets (http://www.researchandmarkets.com/research/5gm54z/chinese_cro) has announced the addition of the "Chinese CRO Company Report - ShangPharma" company profile to their offering.
The booming Chinese pharma outsourcing service industry has fostered the emergence of a large number of professional service providers in China in the past decade. A number of them have gained sufficient capabilities and become as competent as those top tier players in the same service sector of the global pharma outsourcing industry.
To help global pharma outsourcing companies and professional service providers as well as venture capital investors better understand the current development state of this Chinese industry, we have successfully identified the current top five players of the Chinese pharma outsourcing service industry, and published them in this series of Company Reports. The selection is based on the results of the in-depth evaluation against each and every Chinese/China-based service provider out of a vast pool of service companies in JZMed's database.
In this report a complete description and an in-depth analysis about ShangPharma is presented. The report is a valuable reference to global pharmaceutical, biotechnology, financial investment and outsourcing service companies that are interested in gaining better understanding about the current development state and future growth potentials of ShangPharma as well as the entire Chinese pharma outsourcing service industry.
Scope of the Report
Following subjects are addressed in detail in this report:
- Evaluation of ShangPharma's current service scope and capability;
- Analysis of ShangPharma's current service strengths and weaknesses;
- Analysis of ShangPharma's current service revenue performance and its growth history;
- Main collaborations of ShangPharma with multinational companies;
- Analysis of ShangPharma's current key competitors in domestic and international markets;
- Analysis of future growth potentials of ShangPharma.
Besides, the report also includes the in-depth analysis and detailed discussions about the current state of the Chinese pharma outsourcing service industry including its current market size and past growth history, and the future growth potentials of this Chinese market including its growth drivers and resistors.
Key Topics Covered:
Part One - Current State of Chinese Pharma Outsourcing service Industry
Part Two - Analysis of Current State of ShangPharma
Part Three - Main Collaborations of ShangPharma with Global Pharma and Biopharma Companies
Part Four - Analysis of Future Growth Potentials of Chinese Pharma Outsourcing Service Market
Part Five - Analysis of Future Growth Potentials of ShangPharma
Company Profile of ShangPharma
For more information visit http://www.researchandmarkets.com/research/5gm54z/chinese_cro